批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 1984/07/10 |
ORIG-1(原始申请) |
Approval |
Type 4 - New Combination |
STANDARD
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2019/06/14 |
SUPPL-50(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2018/05/21 |
SUPPL-49(补充) |
Approval |
Labeling-Package Insert,Labeling-Patient Package Insert |
STANDARD
|
|
|
| 2014/04/21 |
SUPPL-46(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2009/05/11 |
SUPPL-42(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2008/01/25 |
SUPPL-38(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2003/03/27 |
SUPPL-25(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2002/01/10 |
SUPPL-24(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
| 2001/10/03 |
SUPPL-22(补充) |
Approval |
Efficacy-New Patient Population |
STANDARD
|
|
|
| 2001/10/03 |
SUPPL-20(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2001/10/03 |
SUPPL-9(补充) |
Approval |
Labeling |
|
|
|
| 2001/10/03 |
SUPPL-7(补充) |
Approval |
Labeling |
|
|
|
| 2001/02/28 |
SUPPL-21(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
| 2000/02/02 |
SUPPL-19(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
| 1999/05/14 |
SUPPL-18(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
| 1998/11/10 |
SUPPL-17(补充) |
Approval |
Manufacturing (CMC)-Packaging |
STANDARD
|
|
|
| 1998/07/31 |
SUPPL-15(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
| 1998/06/15 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
| 1998/05/18 |
SUPPL-16(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
| 1995/01/30 |
SUPPL-12(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
| 1995/01/30 |
SUPPL-11(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 1994/10/06 |
SUPPL-10(补充) |
Approval |
Manufacturing (CMC)-Packaging |
STANDARD
|
|
|
| 1990/09/11 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
| 1990/08/01 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
| 1987/10/29 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 1986/09/12 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 1986/05/20 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
| 1986/04/23 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 1985/02/22 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC)-Packaging |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
| 关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
| 无 |
与本品治疗等效的药品
>>>活性成分:BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE; 剂型/给药途径:CREAM;TOPICAL; 规格:EQ 0.05% BASE;1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 治疗等效代码:AB<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 018827 |
001 |
NDA |
LOTRISONE |
BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE |
CREAM;TOPICAL |
EQ 0.05% BASE;1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
Discontinued |
Yes |
No |
AB |
1984/07/10
|
ORGANON |